Molony DA - Search Results

1

Survival differences between peritoneal dialysis and hemodialysis among "large" ESRD patients in the United States.

Stack AG, Murthy BV, Molony DA. Stack AG, et al. Among authors: molony da. Kidney Int. 2004 Jun;65(6):2398-408. doi: 10.1111/j.1523-1755.2004.00654.x. Kidney Int. 2004. PMID: 15149353 Free article.

2

Na+:K+:2Cl- cotransport and the thick ascending limb.

Molony DA, Reeves WB, Andreoli TE. Molony DA, et al. Kidney Int. 1989 Sep;36(3):418-26. doi: 10.1038/ki.1989.211. Kidney Int. 1989. PMID: 2687569 Free article. Review. No abstract available.

3

Effective clearance of methotrexate using high-flux hemodialysis membranes.

Wall SM, Johansen MJ, Molony DA, DuBose TD Jr, Jaffe N, Madden T. Wall SM, et al. Among authors: molony da. Am J Kidney Dis. 1996 Dec;28(6):846-54. doi: 10.1016/s0272-6386(96)90384-4. Am J Kidney Dis. 1996. PMID: 8957036

4

Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.

Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Stack AG, et al. Among authors: molony da. Kidney Int. 2003 Sep;64(3):1071-9. doi: 10.1046/j.1523-1755.2003.00165.x. Kidney Int. 2003. PMID: 12911559 Free article.

5

Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race.

Murthy BV, Molony DA, Stack AG. Murthy BV, et al. Among authors: molony da. J Am Soc Nephrol. 2005 Mar;16(3):782-90. doi: 10.1681/ASN.2004080627. Epub 2005 Jan 26. J Am Soc Nephrol. 2005. PMID: 15677309

6

Association of physical activity with mortality in the US dialysis population.

Stack AG, Molony DA, Rives T, Tyson J, Murthy BV. Stack AG, et al. Among authors: molony da. Am J Kidney Dis. 2005 Apr;45(4):690-701. doi: 10.1053/j.ajkd.2004.12.013. Am J Kidney Dis. 2005. PMID: 15806472

7

Accumulation of metals and minerals from phosphate binders.

Molony DA, Murthy B. Molony DA, et al. Blood Purif. 2005;23 Suppl 1:2-11. doi: 10.1159/000083712. Blood Purif. 2005. PMID: 15832017 Review.

8

Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.

Molony DA, Stephens BW. Molony DA, et al. Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004. Adv Chronic Kidney Dis. 2011. PMID: 21406297 Review.

9

Immunosuppressive agents for treating IgA nephropathy.

Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Samuels JA, et al. Among authors: molony da. Cochrane Database Syst Rev. 2003;(4):CD003965. doi: 10.1002/14651858.CD003965. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2015 Aug 03;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. PMID: 14584001 Updated. Review.

10

Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura.

Samuel JP, Bell CS, Molony DA, Braun MC. Samuel JP, et al. Among authors: molony da. Clin J Am Soc Nephrol. 2011 Aug;6(8):2034-40. doi: 10.2215/CJN.01410211. Epub 2011 Jun 23. Clin J Am Soc Nephrol. 2011. PMID: 21700827 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters